Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.
Wu Zhichao, Medeiros Felipe A, Weinreb Robert N, Zangwill Linda M
AI Summary
Comparing 10-2 and central 24-2 visual fields for glaucoma detection, both tests showed similar sensitivity for central abnormalities. This suggests the 10-2 test may not offer a significant advantage over central 24-2 for initial detection.
Abstract
Purpose
To compare the performance of the pattern standard deviation (PSD) values derived from the central 12 locations of the 24-2 visual field test (C24-2) to the entire 10-2 test for detecting central visual field abnormalities in eyes with, suspected of having, or at risk of having glaucoma.
Design
Cross-sectional case-control study.
Methods
Eyes with, suspected of having, or at risk of having glaucoma, based on masked grading of optic disc stereophotographs and/or ocular hypertension (intraocular pressure ≥ 22 mm Hg) were included as cases (n = 523). Eyes from healthy participants were included as controls (n = 107) to allow the 2 tests to be compared at matched specificities. The sensitivity to detect cases at 95% specificity using PSD values derived from the entire 10-2 test and C24-2 were compared.
Results
The sensitivity of the 10-2 and C24-2 PSD values was not significantly different between the 10-2 and C24-2 at matched specificities (35.9% and 35.4% respectively; P = .900). There was also a substantial agreement between the cases detected by both methods (kappa = 0.80 ± 0.04), and a very strong association between the PSD values from the 2 methods (R 2 = 0.91).
Conclusions
10-2 and 24-2 tests identified a similar number of eyes with, suspected of having, or at risk of having glaucoma as having central visual field abnormalities using PSD values. These findings do not mean that 10-2 tests are not useful, but highlight the need for further studies to determine the potential advantages of 10-2 tests through equivalent comparisons against 24-2 tests to ensure appropriate recommendations are made about its incorporation into the glaucoma standard of care.
MeSH Terms
Shields Classification
Key Concepts4
The sensitivity of the 10-2 visual field test and the central 12 locations of the 24-2 visual field test (C24-2) pattern standard deviation (PSD) values for detecting central visual field abnormalities was not significantly different at matched specificities (35.9% and 35.4% respectively; P = .900) in a cross-sectional case-control study of 523 eyes with, suspected of having, or at risk of having glaucoma and 107 eyes from healthy participants.
There was a substantial agreement between the cases detected by the 10-2 visual field test and the central 12 locations of the 24-2 visual field test (C24-2) pattern standard deviation (PSD) values (kappa = 0.80 ± 0.04) in a cross-sectional case-control study of 523 eyes with, suspected of having, or at risk of having glaucoma and 107 eyes from healthy participants.
There was a very strong association between the pattern standard deviation (PSD) values from the 10-2 visual field test and the central 12 locations of the 24-2 visual field test (C24-2) (R^2 = 0.91) in a cross-sectional case-control study of 523 eyes with, suspected of having, or at risk of having glaucoma and 107 eyes from healthy participants.
The 10-2 and 24-2 visual field tests identified a similar number of eyes with, suspected of having, or at risk of having glaucoma as having central visual field abnormalities using pattern standard deviation (PSD) values, based on a cross-sectional case-control study of 523 eyes with, suspected of having, or at risk of having glaucoma and 107 eyes from healthy participants.
Related Articles5
Evaluation of visual function and OCT parameters in ethambutol-induced optic neuropathy: a longitudinal study.
Cohort StudyVisual Field Progression Rates in Glaucoma: Frontloaded Versus Clinical Standard (Nonfrontloaded) SITA-Faster.
Observational StudyEndpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study.
Clinical TrialPrimary Visual Pathway Changes in Individuals With Chronic Mild Traumatic Brain Injury.
Case-Control StudyVisual field testing in glaucoma using the Swedish Interactive Thresholding Algorithm (SITA).
ReviewIs this article assigned to the wrong chapter(s)? Let us know.